Vestibular Migraine: Clinical Trials

6 trials for Vestibular Migraine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 1 active not recruiting, 1 withdrawn. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 31Completed 1

Follow Vestibular Migraine: new trials by email Literature Review of Vestibular Migraine trials Research Report on Vestibular Migraine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study
Rimegepant, Flunarizine - Vestibular Migraine
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine4002026-12-012026-08-07
The R-E-V-I-V-A-L Study
Rimegepant, Placebo - Vestibular Migraine
Phase 2Active not recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2402025-06-012025-06-25
A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment
Rimegepant, Placebo - Vestibular Migraine, Adults 18 Years and Older (no Other Exclusion Criteria)
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2402025-06-012025-05-14
Galcanezumab for Vestibular Migraine
Galcanezumab Prefilled Syringe, Placebo - Vestibular Migraine
Phase 2CompletedUniversity of California, San Francisco402020-09-182024-12-10
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
4-aminopyridine, Atenolol, Placebo - Vestibular Migraine, Migraine Disorders
Phase 2WithdrawnMassachusetts Eye and Ear Infirmary2019-01-012024-07-01
Rizatriptan for Episodic Dizziness in Vestibular Migraine
Rizatriptan, Placebo - Vestibular Migraine, Migrainous Vertigo
Phase 2 / Phase 3CompletedRobert W. Baloh2232014-12-012021-11-04

Narrower conditions

Migraine Disorders (1)  ·  Vestibular Diseases (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Ear Diseases (1)  ·  Headache Disorders (1)  ·  Headache Disorders, Primary (1)  ·  Labyrinth Diseases (1)  ·  Nervous System Diseases (1)  ·  Otorhinolaryngologic Diseases (1)

Interventions

rimegepant sulfate (3)  ·  4-Aminopyridine (1)  ·  Atenolol (1)  ·  Flunarizine (1)  ·  Sugars (1)  ·  erenumab (1)  ·  rizatriptan (1)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (3)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Robert W. Baloh (1)  ·  University of California, San Francisco (1)

Countries

United States (3)  ·  China (2)

Top investigators

Jeffrey D Sharon, MD (1)  ·  Robert W Baloh, M.D. (1)

Results publications

PMID 39344988, PMID 11222783, PMID 26224714, PMID 30020261, PMID 31311674, PMID 36946234, PMID 37042545, PMID 37073858, PMID 37210098, PMID 40354049, PMID 41430107